nordimet
nordic group b.v. - methotrexat - arthritis, psoriatic; psoriasis; arthritis, juvenile rheumatoid; arthritis, rheumatoid - antineoplastiske midler - nordimet is indicated for the treatment of:active rheumatoid arthritis in adult patients,polyarthritic forms of severe, active juvenile idiopathic arthritis (jia), when the response to nonsteroidal anti-inflammatory drugs (nsaids) has been inadequate,moderate to severe plaque psoriasis in adults who are candidates for systemic therapy, and severe psoriatic arthritis in adult patients, induction of remission in moderate steroid-dependent crohn's disease in adult patients, in combination with corticosteroids and for maintenance of remission, as monotherapy, in patients who have responded to methotrexate.
pentasa 1 g depottabletter
paranova danmark a/s - mesalazin - depottabletter - 1 g
pentasa 1 g depottabletter
orifarm a/s - mesalazin - depottabletter - 1 g
pentasa 500 mg depottabletter
ferring lægemidler a/s - mesalazin - depottabletter - 500 mg
pentasa 500 mg depottabletter
orifarm a/s - mesalazin - depottabletter - 500 mg
pentasa 500 mg depottabletter
2care4 aps - mesalazin - depottabletter - 500 mg
pentasa 1 g rektalvæske, suspension, enkeltdosisbeholder
ferring lægemidler a/s - mesalazin - rektalvæske, suspension, enkeltdosisbeholder - 1 g
pentasa 1 g rektalvæske, suspension, enkeltdosisbeholder
orifarm a/s - mesalazin - rektalvæske, suspension, enkeltdosisbeholder - 1 g
pentasa 1 g suppositorier
ferring lægemidler a/s - mesalazin - suppositorier - 1 g
pentasa 1 g suppositorier
orifarm a/s - mesalazin - suppositorier - 1 g